Related Experiment Videos
Acrodermatitis enteropathica, zinc metabolism, copper status, and immune function
B Sandström1, A Cederblad, B S Lindblad
1Research Department of Human Nutrition, Royal Veterinary and Agricultural University, Frederiksberg, Denmark.
Archives of Pediatrics & Adolescent Medicine
|September 1, 1994
Summary
Acrodermatitis enteropathica treatment requires careful zinc dosage monitoring. Excessive zinc supplementation can impair copper status and immune function, necessitating adjustments for optimal patient health.
Area of Science:
- Biochemistry
- Immunology
- Nutritional Science
Background:
- Acrodermatitis enteropathica (AE) is a rare genetic disorder affecting zinc absorption.
- Understanding zinc metabolism is crucial for managing AE patients.
Observation:
- A 16-year-old AE patient's zinc metabolism, copper status, and immune function were studied.
- Zinc supplementation dosage was adjusted from 1000 to 525 μmol/day.
Findings:
- High-dose zinc supplementation led to low copper status and immune dysfunction.
- Lowering zinc dosage normalized copper and immune parameters.
- Zinc absorption was within normal ranges, suggesting a cellular defect in metabolism, not absorption.
Implications:
- AE management requires individualized zinc dosage adjustments.
- Regular monitoring of zinc, copper, and immune status is essential for AE patients.
- Findings suggest AE's primary defect is cellular zinc metabolism, not absorption.